$1.36
-0.01-0.73%
Pre-Market: 4:31 PM EDT
15 minutes delayed
Comments
Loading...
Akebia Therapeutics (AKBA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAkebia Therapeutics (NASDAQ:AKBA) Stock Quotes, Forecast and News Summary
Akebia Therapeutics Stock (NASDAQ: AKBA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 2.70M |
| Day Range | - - - |
| 52 Wk Range | 0.78 - 2.48 |
| Market Cap | $285.99M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 9.17% |
| Days to Cover | 11.43 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Akebia Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating seg...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akebia Therapeutics (AKBA) stock?
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Who are Akebia Therapeutics (AKBA) competitors?
Other companies in Akebia Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Akebia Therapeutics (AKBA) stock?
Akebia Therapeutics has a consensus price target of $3.90.
What is the current price for Akebia Therapeutics (AKBA)?
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.36 last updated September 19, 2024 at 4:31 PM EDT.
Does Akebia Therapeutics (AKBA) pay a dividend?
There are no upcoming dividends for Akebia Therapeutics.
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
Akebia Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Akebia Therapeutics (AKBA) going to split?
There is no upcoming split for Akebia Therapeutics.
What sector and industry does Akebia Therapeutics (AKBA) operate in?
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.